Glucagonoma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Glucagonoma}} | {{Glucagonoma}} | ||
{{CMG}} | {{CMG}}{{AE}}{{PSD}} | ||
==Overview== | ==Overview== | ||
Secondary prevention measures of glucagonoma include routine glucagon and imaging at scheduled intervals after treatment.<ref name="pmid23681843">{{cite journal| author=Halvorson SA, Gilbert E, Hopkins RS, Liu H, Lopez C, Chu M et al.| title=Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome. | journal=J Gen Intern Med | year= 2013 | volume= 28 | issue= 11 | pages= 1525-9 | pmid=23681843 | doi=10.1007/s11606-013-2490-5 | pmc=PMC3797362 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23681843 }} </ref> | |||
==Secondary Prevention== | ==Secondary Prevention== | ||
Secondary prevention measures of glucagonoma include routine glucagon and imaging at 3 and 6 months post-resection, and every 6 to 12 months thereafter.<ref name="pmid23681843">{{cite journal| author=Halvorson SA, Gilbert E, Hopkins RS, Liu H, Lopez C, Chu M et al.| title=Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome. | journal=J Gen Intern Med | year= 2013 | volume= 28 | issue= 11 | pages= 1525-9 | pmid=23681843 | doi=10.1007/s11606-013-2490-5 | pmc=PMC3797362 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23681843 }} </ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 18:25, 13 October 2015
|
Glucagonoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Glucagonoma secondary prevention On the Web |
|
American Roentgen Ray Society Images of Glucagonoma secondary prevention |
|
Risk calculators and risk factors for Glucagonoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overview
Secondary prevention measures of glucagonoma include routine glucagon and imaging at scheduled intervals after treatment.[1]
Secondary Prevention
Secondary prevention measures of glucagonoma include routine glucagon and imaging at 3 and 6 months post-resection, and every 6 to 12 months thereafter.[1]
References
- ↑ 1.0 1.1 Halvorson SA, Gilbert E, Hopkins RS, Liu H, Lopez C, Chu M; et al. (2013). "Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome". J Gen Intern Med. 28 (11): 1525–9. doi:10.1007/s11606-013-2490-5. PMC 3797362. PMID 23681843.